Survival benefits of Cytoreductive Nephrectomy in patients with metastatic renal cell carcinoma: evidence from a SEER-based retrospective cohort study.

Survival benefits of Cytoreductive Nephrectomy in patients with metastatic renal cell carcinoma: evidence from a SEER-based retrospective cohort study.

Show other versions (1)

<h4>Background</h4>Metastatic renal cell carcinoma (mRCC) is associated with poor prognosis, with a 5-year survival rate of less than 15%. Cytoreductive nephrectomy (CN) has historically played a critical role in mRCC management, potentially enhancing systemic therapy efficacy by reducin...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiongwu Peng, Lingxing Duan, Qi Wu, Shiping Wu, Wenfeng Wang, Runlin Shi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0318896
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items